Biochips

Biochips

Global Biochips Market to Reach $28.5 Billion by 2027
In the changed post COVID-19 business landscape, the global market for Biochips estimated at US$13.1 Billion in the year 2020, is projected to reach a revised size of US$28.5 Billion by 2027, growing at a CAGR of 11.7% over the analysis period 2020-2027. DNA Chip, one of the segments analyzed in the report, is projected to record a 10.6% CAGR and reach US$9.7 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Lab-On-a-chip segment is readjusted to a revised 12.3% CAGR for the next 7-year period.

The U.S. Market is Estimated at $5.3 Billion, While China is Forecast to Grow at 13.9% CAGR
The Biochips market in the U.S. is estimated at US$5.3 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.8 Billion by the year 2027 trailing a CAGR of 13.9% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 9.9% and 10.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 11.7% CAGR.Protein Chip Segment to Record 13% CAGR
In the global Protein Chip segment, USA, Canada, Japan, China and Europe will drive the 13% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$2.2 Billion in the year 2020 will reach a projected size of US$5.1 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets.

Select Competitors (Total 69 Featured) -

  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • CapitalBio Technology Inc.
  • Cepheid Inc.
  • Fluidigm Corporation
  • Hoffman-La-Roche Ltd.
  • Illumina, Inc.
  • OcimumBiosolutions Ltd.
  • PerkinElmer, Inc.
  • Takara Bio Inc.
  • Takara Bio USA, Inc.
  • Thermo Fisher Scientific Inc.
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
2020 Marked as a Year of Disruption & Transformation
World Economic Growth Projections (Real GDP, Annual % Change) for 2019 to 2022
Biotechnology Sector Performance amid the Pandemic
Global Biotechnology Market Reset & Trajectory - Growth Outlook (In %) For Years 2019 Through 2025
Biochip Firms Get Ready to Address COVID-19 Challenge
Biochips – Global Key Competitors Percentage Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
Biochips: A Primer
Manufacturing Systems Used in Biochip Manufacture
Historical Perspective
Classification of Biochips
Application Markets
Market Outlook
Protein Biochips Set for Expansion
Recent Technological Advancements Drive Wider Adoption of Biochips
Competition
Biotech Startups Pose Competition
Recent Market Activity
World Brands
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Biochips Seek Increasing Role in POC Testing
Biochips to Help Next-Generation Sequencing Scale New Heights & Unravel Intimidating Biological Problems
Research Forays into Organ-On-A-Chip (OOC)
OCC Start-Ups Enter the Fray
Select Organ-On-A-Chip Start-Ups & Their Specialties
Biochip Implants Set to Make Big Gains
Biochips Aid in Alleviating Issues Associated with Immunological Studies
Challenges for Widespread Adoption
Drug Discovery Applications to Drive Market
Growing Preference for DNA/Protein Biochips in Personalized Medicine
Global Personalized Medicine Market: Revenues in US$ Million for the Years 2019, 2021, 2023 and 2025
Microphysiological Systems to Take Personalized Medicine Much Farther
Biochip Array Technology Enables Reliable and Accurate Investigation of Metabolic Syndrome
Proteomics and Genomics Drive Opportunities for Biochips
Increasing Application of Genomics and Proteomics in Cancer Diagnostics and Treatment to Drive Growth
Breakdown of Total Number of Cancer Cases by Region: 2020
Breakdown of Total Number of Cancer Cases by Type: 2020
Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
Potential Application of Biochips in Diabetes Diagnosis and Management Unfurl New Growth Opportunities
World Diabetes and Population Statistics (2019, 2030 & 2045)
World Diabetes Prevalence (2000-2019)
Rise in Infectious Diseases and Need for High-Troughput Diagnosis Drive Interest in Biochips
Infection Rates of Viruses ((per infected person)) Involved in Outbreaks Worldwide: 2020
Infectious Diseases Related Mortality High Among Children Below 5 Years: Breakdown of Leading Causes of Death in Children Below 5 Years (in %)
Global Number of Deaths Caused Due to Communicable Diseases (In 000s)
Agriculture Sector: Niche Vertical
Development of Protein Microarrays for the Field of Diagnostics: Key Challenges
Biochip Industry Thrives on Innovation
Researchers at UCI Develop Machine Learning-Assisted Biochip
New Biochip Combines Nanoparticle Printing and AI for Tumor Analysis
Axbio Introduces Smartbiochip
Multi-Dimensional Printing Technology Enables Development of New Biochip Printing Technique
MIT Develops Neuromorphic Chip Capable of Mimicking Human Brain
Biochips from AYOXXA: A Giant Leap in Protein Multiplexing
Biochip Innovations in Drug Discovery Applications
Industry Challenges
Standardization: A Key Challenge
High Costs Restrain Growth
Precise Protein Detection: A Challenge
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Recent Past, Current & Future Analysis for DNA Chip by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 2: World Historic Review for DNA Chip by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 3: World 15-Year Perspective for DNA Chip by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2012, 2021 & 2027
TABLE 4: World Recent Past, Current & Future Analysis for Lab-on-a-Chip by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 5: World Historic Review for Lab-on-a-Chip by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 6: World 15-Year Perspective for Lab-on-a-Chip by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2012, 2021 & 2027
TABLE 7: World Recent Past, Current & Future Analysis for Protein Chip by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 8: World Historic Review for Protein Chip by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 9: World 15-Year Perspective for Protein Chip by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2012, 2021 & 2027
TABLE 10: World Recent Past, Current & Future Analysis for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 11: World Historic Review for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 12: World 15-Year Perspective for Other Product Types by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2012, 2021 & 2027
TABLE 13: World Recent Past, Current & Future Analysis for Drug Discovery & Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 14: World Historic Review for Drug Discovery & Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 15: World 15-Year Perspective for Drug Discovery & Development by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2012, 2021 & 2027
TABLE 16: World Recent Past, Current & Future Analysis for Disease Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 17: World Historic Review for Disease Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 18: World 15-Year Perspective for Disease Diagnostics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2012, 2021 & 2027
TABLE 19: World Recent Past, Current & Future Analysis for Genomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 20: World Historic Review for Genomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 21: World 15-Year Perspective for Genomics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2012, 2021 & 2027
TABLE 22: World Recent Past, Current & Future Analysis for Proteomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 23: World Historic Review for Proteomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 24: World 15-Year Perspective for Proteomics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2012, 2021 & 2027
TABLE 25: World Recent Past, Current & Future Analysis for Agriculture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 26: World Historic Review for Agriculture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 27: World 15-Year Perspective for Agriculture by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2012, 2021 & 2027
TABLE 28: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 29: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 30: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2012, 2021 & 2027
TABLE 31: World Recent Past, Current & Future Analysis for Biochips by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 32: World Historic Review for Biochips by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 33: World 15-Year Perspective for Biochips by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2012, 2021 & 2027
III. MARKET ANALYSIS
UNITED STATES
Biochips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E)
TABLE 34: USA Recent Past, Current & Future Analysis for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 35: USA Historic Review for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 36: USA 15-Year Perspective for Biochips by Product Type - Percentage Breakdown of Value Revenues for DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types for the Years 2012, 2021 & 2027
TABLE 37: USA Recent Past, Current & Future Analysis for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 38: USA Historic Review for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 39: USA 15-Year Perspective for Biochips by Application - Percentage Breakdown of Value Revenues for Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications for the Years 2012, 2021 & 2027
CANADA
TABLE 40: Canada Recent Past, Current & Future Analysis for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 41: Canada Historic Review for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 42: Canada 15-Year Perspective for Biochips by Product Type - Percentage Breakdown of Value Revenues for DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types for the Years 2012, 2021 & 2027
TABLE 43: Canada Recent Past, Current & Future Analysis for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 44: Canada Historic Review for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 45: Canada 15-Year Perspective for Biochips by Application - Percentage Breakdown of Value Revenues for Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications for the Years 2012, 2021 & 2027
JAPAN
Biochips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E)
TABLE 46: Japan Recent Past, Current & Future Analysis for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 47: Japan Historic Review for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 48: Japan 15-Year Perspective for Biochips by Product Type - Percentage Breakdown of Value Revenues for DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types for the Years 2012, 2021 & 2027
TABLE 49: Japan Recent Past, Current & Future Analysis for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 50: Japan Historic Review for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 51: Japan 15-Year Perspective for Biochips by Application - Percentage Breakdown of Value Revenues for Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications for the Years 2012, 2021 & 2027
CHINA
Biochips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E)
TABLE 52: China Recent Past, Current & Future Analysis for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 53: China Historic Review for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 54: China 15-Year Perspective for Biochips by Product Type - Percentage Breakdown of Value Revenues for DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types for the Years 2012, 2021 & 2027
TABLE 55: China Recent Past, Current & Future Analysis for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 56: China Historic Review for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 57: China 15-Year Perspective for Biochips by Application - Percentage Breakdown of Value Revenues for Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications for the Years 2012, 2021 & 2027
EUROPE
Biochips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E)
TABLE 58: Europe Recent Past, Current & Future Analysis for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 59: Europe Historic Review for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 60: Europe 15-Year Perspective for Biochips by Product Type - Percentage Breakdown of Value Revenues for DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types for the Years 2012, 2021 & 2027
TABLE 61: Europe Recent Past, Current & Future Analysis for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 62: Europe Historic Review for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 63: Europe 15-Year Perspective for Biochips by Application - Percentage Breakdown of Value Revenues for Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications for the Years 2012, 2021 & 2027
TABLE 64: Europe Recent Past, Current & Future Analysis for Biochips by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 65: Europe Historic Review for Biochips by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 66: Europe 15-Year Perspective for Biochips by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2021 & 2027
FRANCE
Biochips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E)
TABLE 67: France Recent Past, Current & Future Analysis for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 68: France Historic Review for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 69: France 15-Year Perspective for Biochips by Product Type - Percentage Breakdown of Value Revenues for DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types for the Years 2012, 2021 & 2027
TABLE 70: France Recent Past, Current & Future Analysis for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 71: France Historic Review for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 72: France 15-Year Perspective for Biochips by Application - Percentage Breakdown of Value Revenues for Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications for the Years 2012, 2021 & 2027
GERMANY
Biochips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E)
TABLE 73: Germany Recent Past, Current & Future Analysis for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 74: Germany Historic Review for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 75: Germany 15-Year Perspective for Biochips by Product Type - Percentage Breakdown of Value Revenues for DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types for the Years 2012, 2021 & 2027
TABLE 76: Germany Recent Past, Current & Future Analysis for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 77: Germany Historic Review for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 78: Germany 15-Year Perspective for Biochips by Application - Percentage Breakdown of Value Revenues for Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications for the Years 2012, 2021 & 2027
ITALY
TABLE 79: Italy Recent Past, Current & Future Analysis for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 80: Italy Historic Review for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 81: Italy 15-Year Perspective for Biochips by Product Type - Percentage Breakdown of Value Revenues for DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types for the Years 2012, 2021 & 2027
TABLE 82: Italy Recent Past, Current & Future Analysis for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 83: Italy Historic Review for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 84: Italy 15-Year Perspective for Biochips by Application - Percentage Breakdown of Value Revenues for Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications for the Years 2012, 2021 & 2027
UNITED KINGDOM
Biochips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E)
TABLE 85: UK Recent Past, Current & Future Analysis for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 86: UK Historic Review for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 87: UK 15-Year Perspective for Biochips by Product Type - Percentage Breakdown of Value Revenues for DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types for the Years 2012, 2021 & 2027
TABLE 88: UK Recent Past, Current & Future Analysis for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 89: UK Historic Review for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 90: UK 15-Year Perspective for Biochips by Application - Percentage Breakdown of Value Revenues for Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications for the Years 2012, 2021 & 2027
SPAIN
TABLE 91: Spain Recent Past, Current & Future Analysis for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 92: Spain Historic Review for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 93: Spain 15-Year Perspective for Biochips by Product Type - Percentage Breakdown of Value Revenues for DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types for the Years 2012, 2021 & 2027
TABLE 94: Spain Recent Past, Current & Future Analysis for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 95: Spain Historic Review for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 96: Spain 15-Year Perspective for Biochips by Application - Percentage Breakdown of Value Revenues for Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications for the Years 2012, 2021 & 2027
RUSSIA
TABLE 97: Russia Recent Past, Current & Future Analysis for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 98: Russia Historic Review for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 99: Russia 15-Year Perspective for Biochips by Product Type - Percentage Breakdown of Value Revenues for DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types for the Years 2012, 2021 & 2027
TABLE 100: Russia Recent Past, Current & Future Analysis for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 101: Russia Historic Review for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 102: Russia 15-Year Perspective for Biochips by Application - Percentage Breakdown of Value Revenues for Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications for the Years 2012, 2021 & 2027
REST OF EUROPE
TABLE 103: Rest of Europe Recent Past, Current & Future Analysis for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 104: Rest of Europe Historic Review for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 105: Rest of Europe 15-Year Perspective for Biochips by Product Type - Percentage Breakdown of Value Revenues for DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types for the Years 2012, 2021 & 2027
TABLE 106: Rest of Europe Recent Past, Current & Future Analysis for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 107: Rest of Europe Historic Review for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 108: Rest of Europe 15-Year Perspective for Biochips by Application - Percentage Breakdown of Value Revenues for Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications for the Years 2012, 2021 & 2027
ASIA-PACIFIC
Biochips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E)
TABLE 109: Asia-Pacific Recent Past, Current & Future Analysis for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 110: Asia-Pacific Historic Review for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 111: Asia-Pacific 15-Year Perspective for Biochips by Product Type - Percentage Breakdown of Value Revenues for DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types for the Years 2012, 2021 & 2027
TABLE 112: Asia-Pacific Recent Past, Current & Future Analysis for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 113: Asia-Pacific Historic Review for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 114: Asia-Pacific 15-Year Perspective for Biochips by Application - Percentage Breakdown of Value Revenues for Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications for the Years 2012, 2021 & 2027
LATIN AMERICA
Biochips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2022 (E)
TABLE 115: Latin America Recent Past, Current & Future Analysis for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 116: Latin America Historic Review for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 117: Latin America 15-Year Perspective for Biochips by Product Type - Percentage Breakdown of Value Revenues for DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types for the Years 2012, 2021 & 2027
TABLE 118: Latin America Recent Past, Current & Future Analysis for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 119: Latin America Historic Review for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 120: Latin America 15-Year Perspective for Biochips by Application - Percentage Breakdown of Value Revenues for Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications for the Years 2012, 2021 & 2027
REST OF WORLD
TABLE 121: Rest of World Recent Past, Current & Future Analysis for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 122: Rest of World Historic Review for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 123: Rest of World 15-Year Perspective for Biochips by Product Type - Percentage Breakdown of Value Revenues for DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types for the Years 2012, 2021 & 2027
TABLE 124: Rest of World Recent Past, Current & Future Analysis for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 125: Rest of World Historic Review for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 126: Rest of World 15-Year Perspective for Biochips by Application - Percentage Breakdown of Value Revenues for Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications for the Years 2012, 2021 & 2027
IV. COMPETITION
Total Companies Profiled: 69

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings